تفاعل #1726693

ord-5dc98127805b4843b7c9b7cfbe9a0af5

معادلة التفاعل

CCOC(=O)c1nnc(-c2ccc(OC(F)F)cc2)o1
7A
CCOC(=O)c1nnc(-c2ccc(OC(F)F)cc2)o1
Ethyl 5-(4-(difluoromethoxy)phenyl)-1,3,4-oxadiazole-2-carboxylate
c1cc(OC2CNC2)ccc1CN1CC2(COC2)C1
3B
c1cc(OC2CNC2)ccc1CN1CC2(COC2)C1
6-(4-(Azetidin-3-yloxy)benzyl)-2-oxa-6-azaspiro[3.3]heptane
O=C(c1nnc(-c2ccc(OC(F)F)cc2)o1)N1CC(Oc2ccc(CN3CC4(COC4)C3)cc2)C1
7
المردود 68.6%
O=C(c1nnc(-c2ccc(OC(F)F)cc2)o1)N1CC(Oc2ccc(CN3CC4(COC4)C3)cc2)C1
(3-(4-(2-Oxa-6-azaspiro[3.3]heptan-6-ylmethyl)phenoxy)azetidin-1-yl)(5-(4-(difluoromethoxy)phenyl)-1,3,4-oxadiazol-2-yl)methanone
المردود 68.6%

ظروف التفاعل

الظروف التفصيلية
See reaction.notes.procedure_details.

الإجراء التجريبي

Using a similar protocol as described in Example 6 but employing 7A (60 mg, 0.21 mmol) and 3B (50 mg, 0.19 mmol) as starting materials afforded 65 mg (68%) of 7 as a solid. 1H NMR (500 MHz, CDCl3): δ 3.0-4.2 (m, 6H), 4.34 (m, 1H), 4.66 (m, 1H), 4.76 (m, 5H), 5.10 (m, 2H), 6.62 (t, 1H), 6.76 (m, 2H), 7.27 (m, 4H), 8.18 (d, 2H), MS (APCI+) m/z 499 [M+H]+, LC purity: 96%.

المصدر

DOI: 10.6084/m9.figshare.5104873.v1براءة الاختراع: US08110566B2uspto-grants-2012_02